- Peptide Substrates
- Binding Proteins
- Secondary Antibodies
- Regulatory proteins
- 脂类激酶
- 双加氧酶与蛋白质
- 脂质底物
- E2
- Assay Buffer and Co-factors
- Methyltransferases
- Acetyltransferases
- Transcription Proteins
- COVID-19 ELISA Kits
- Tau Proteins
- Microtubule & Actin Associated Proteins
- Carbohydrate Substrates
- COVID-19 Proteins
- Chemokines
- 标记抗体
- 授予称号
- E3
- 【桥头火锅】品牌介绍→桥头火锅底料_重庆桥头火锅_买购网
- SignalChem|生产厂家|价格信息
- signalchem
- IL4 Gene GeneCards | IL4 Protein | IL4 Antibody
- 代理产品SignalchemSignalchem
- 重组人IL11说明书
- cell signaling 三天审稿完毕,小修! 论文投稿 交流 ...
- ...SignalChem一级代理,SignalChem中国代理,SignalChem公司_环保...
- “不积极”英语是什么?unactive吗?
- “不积极”英语是什么?unactive吗?
- 苏州蚂蚁淘实验试剂有限公司17年8月份销售过的产品1苏州蚂蚁淘...
- SignalChem安徽代理 |产品目录|代理商|蚂蚁淘进口试剂平行进口
Overview:
Kinase insert domain receptor (KDR or VEGFR) is a growth factor receptor tyrosine kinase that plays a pivotal role in endothelial cell proliferation and differentiation. KDR binds VEGF with high affinity and this interaction is implicated in angiogenesis (1). The expression levels of VEGF and KDR are highly correlated during the normal development of the ocular vasculature in humans (1). Induction of angiogenesis is a critical step in tumor progression, and inhibitors of KDR have been demonstrated both to promote tumor regression and reduce metastatic potential in preclinical studies (2). Autophosphorylation of KDR occurs at Tyr951, Tyr996, Tyr1054 and Tyr1059 and phosphorylation at Tyr1214 is associated with interactions with downstream effector molecules (3).


